Vanda Pharmaceuticals | Zysk Brutto Na Sprzedaży





Zysk Brutto Na Sprzedaży Zmiana Data
Acadia Pharmaceuticals USD 256.99M 13.15M 2025-09
Agios Pharmaceuticals USD 11.2M 448K 2025-09
Akebia Therapeutics USD 49.21M 13.25M 2025-03
Alnylam Pharmaceuticals USD 1.05B 418.14M 2025-09
Anika Therapeutics USD 14.68M 9.46M 2025-03
Arrowhead Research USD 256.47M 228.7M 2025-09
AstraZeneca USD 12.39B 5M 2025-12
Bristol-Myers Squibb USD 8.79B 110M 2025-09
Eli Lilly USD 14.59B 1.48B 2025-09
Enanta Pharmaceuticals -22.29M 23.75M 2024-12
Esperion Therapeutics USD -29.52M 32.4M 2024-09
Halozyme Therapeutics USD 281.77M 2.41M 2025-09
Heron Therapeutics USD 23.35M 1.6M 2024-09
Insmed USD 111.44M 33.36M 2025-09
J&J USD 16.6B 118M 2025-12
Lexicon Pharmaceuticals USD -16.16M 2.89M 2024-06
Ligand Pharmaceuticals USD 155.28M 82.42M 2025-09
Merck USD 13.42B 431M 2025-09
Minerva Neurosciences -4.27M 26.79M 2024-12
Moderna USD 809M 791M 2025-09
Novartis USD 10.82B 694M 2025-09
Pfizer USD 3.54B 7.61B 2025-09
PTC Therapeutics USD 187.69M 24.3M 2025-09
Puma Biotechnology USD 20.32M 24.85M 2024-09
Sangamo BioSciences -2.39M 1.09M 2024-06
Sanofi EUR 8.45B 1.31B 2025-12
Takeda JPY 790.55B 262.97B 2025-12
Teva Pharmaceutical Industries USD 2.66B 351M 2025-12
Ultragenyx Pharmaceutical USD 131.94M 11.55M 2025-09
Vanda Pharmaceuticals USD 50.6M 5.5M 2024-12
Veracyte USD 91.28M 1.51M 2025-09


Vanda Pharmaceuticals Zysk Brutto Na Sprzedaży - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Feb 2026.